Last updated on March 2020

Efficacy Safety and Tolerability of Atogepant for the Prevention of Chronic Migraine

Brief description of study

This study will evaluate the efficacy, safety and tolerability of atogepant in participants with chronic migraine. This study includes a 12-week treatment period.

Clinical Study Identifier: NCT03855137

Find a site near you

Start Over

Ochsner Clinic Foundation

Covington, LA United States
  Connect »